{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:05Z","timestamp":1781639705299,"version":"3.54.5"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019999","name":"Trish Multiple Sclerosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021779","name":"Perpetual","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are devastating adult-onset neurological diseases with distinct pathological manifestations. Although growing evidence implicates copper dysregulation in both diseases, our understanding of this connection remains incomplete. In this study, we investigated metallothionein-3 (MT3), which is a key regulator of copper metabolism in the central nervous system (CNS), and its relationship to copper in the ALS and MS spinal cord. Using combined quantitative mass spectrometry approaches and immunohistochemical observations, we found a significant decrease in ALS and MS spinal cord MT3 levels compared to controls. This was correlated with levels of copper and MT3-copper binding, highlighting a strong relationship between copper and MT3 levels. These findings demonstrate decreased MT3 expression alongside copper as a common feature of ALS and MS supporting previously reported evidence for copper dysregulation in these diseases.<\/jats:p>","DOI":"10.1038\/s41598-025-31283-9","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:05:09Z","timestamp":1772622309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Adam P.","family":"Gunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B. W.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Liddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona A.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"31283_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nchembio.72","volume":"4","author":"BE Kim","year":"2008","unstructured":"Kim, B. E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4, 176\u2013185. https:\/\/doi.org\/10.1038\/nchembio.72 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"31283_CR2","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","volume":"31","author":"T Tsang","year":"2021","unstructured":"Tsang, T., Davis, C. I. & Brady, D. C. Copper biology. Curr. Biol. 31, R421\u2013R427. https:\/\/doi.org\/10.1016\/j.cub.2021.03.054 (2021).","journal-title":"Curr. Biol."},{"key":"31283_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0040-6031(01)00654-2","volume":"381","author":"AA Saboury","year":"2002","unstructured":"Saboury, A. A., Sarri-Sarraf, N. & Saidian, S. Thermodynamics of binding copper ion by Myelin basic protein. Thermochim Acta. 381, 147\u2013151. https:\/\/doi.org\/10.1016\/S0040-6031(01)00654-2 (2002).","journal-title":"Thermochim Acta"},{"key":"31283_CR4","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1016\/j.bpj.2010.08.022","volume":"99","author":"T Bund","year":"2010","unstructured":"Bund, T., Boggs, J. M., Harauz, G., Hellmann, N. & Hinderberger, D. Copper uptake induces self-assembly of 18.5\u00a0kDa Myelin basic protein (MBP). Biophys. J. 99, 3020\u20133028. https:\/\/doi.org\/10.1016\/j.bpj.2010.08.022 (2010).","journal-title":"Biophys. J."},{"key":"31283_CR5","doi-asserted-by":"publisher","first-page":"14556","DOI":"10.1096\/fj.201901606R","volume":"33","author":"C Tavera-Montanez","year":"2019","unstructured":"Tavera-Montanez, C. et al. The classic metal-sensing transcription factor MTF1 promotes myogenesis in response to copper. FASEB J. 33, 14556\u201314574. https:\/\/doi.org\/10.1096\/fj.201901606R (2019).","journal-title":"FASEB J."},{"key":"31283_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1021\/cr040410w","volume":"106","author":"E Gaggelli","year":"2006","unstructured":"Gaggelli, E., Kozlowski, H., Valensin, D. & Valensin, G. Copper homeostasis and neurodegenerative disorders (Alzheimer\u2019s, prion, and parkinson\u2019s diseases and amyotrophic lateral sclerosis). Chem. Rev. 106, 1995\u20132044. https:\/\/doi.org\/10.1021\/cr040410w (2006).","journal-title":"Chem. Rev."},{"key":"31283_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","volume":"9","author":"S Sheykhansari","year":"2018","unstructured":"Sheykhansari, S. et al. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell. Death Dis. 9, 348. https:\/\/doi.org\/10.1038\/s41419-018-0379-2 (2018).","journal-title":"Cell. Death Dis."},{"key":"31283_CR8","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 3, 17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"31283_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers. 4, 43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"31283_CR10","doi-asserted-by":"publisher","first-page":"e73614","DOI":"10.1371\/journal.pone.0073614","volume":"8","author":"V Rajagopalan","year":"2013","unstructured":"Rajagopalan, V. et al. Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study. PLoS One. 8, e73614. https:\/\/doi.org\/10.1371\/journal.pone.0073614 (2013).","journal-title":"PLoS One"},{"key":"31283_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/acn3.51035","volume":"7","author":"MC Gabel","year":"2020","unstructured":"Gabel, M. C. et al. Evolution of white matter damage in amyotrophic lateral sclerosis. Ann. Clin. Transl Neurol. 7, 722\u2013732. https:\/\/doi.org\/10.1002\/acn3.51035 (2020).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"31283_CR12","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.nicl.2021.102863","volume":"32","author":"HJ Chen","year":"2021","unstructured":"Chen, H. J. et al. White matter microstructural impairments in amyotrophic lateral sclerosis: A mean apparent propagator MRI study. Neuroimage Clin. 32, 102863. https:\/\/doi.org\/10.1016\/j.nicl.2021.102863 (2021).","journal-title":"Neuroimage Clin."},{"key":"31283_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp-2014-308241","volume":"86","author":"H Kearney","year":"2015","unstructured":"Kearney, H. et al. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 86, 608\u2013614. https:\/\/doi.org\/10.1136\/jnnp-2014-308241 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"31283_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ana.24241","volume":"76","author":"R Schlaeger","year":"2014","unstructured":"Schlaeger, R. et al. Spinal cord Gray matter atrophy correlates with multiple sclerosis disability. Ann. Neurol. 76, 568\u2013580. https:\/\/doi.org\/10.1002\/ana.24241 (2014).","journal-title":"Ann. Neurol."},{"key":"31283_CR15","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1038\/s41598-024-55832-w","volume":"14","author":"JBW Hilton","year":"2024","unstructured":"Hilton, J. B. W. et al. Evidence for disrupted copper availability in human spinal cord supports Cu(II)(atsm) as a treatment option for sporadic cases of ALS. Sci. Rep. 14, 5929. https:\/\/doi.org\/10.1038\/s41598-024-55832-w (2024).","journal-title":"Sci. Rep."},{"key":"31283_CR16","doi-asserted-by":"publisher","unstructured":"Hilton, J. B. W. et al. Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis. Neurotherapeutics 21, e00432 (2024). https:\/\/doi.org\/10.1016\/j.neurot.2024.e00432","DOI":"10.1016\/j.neurot.2024.e00432"},{"key":"31283_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuro.2007.12.006","volume":"29","author":"AK West","year":"2008","unstructured":"West, A. K., Hidalgo, J., Eddins, D., Levin, E. D. & Aschner, M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 29, 489\u2013503. https:\/\/doi.org\/10.1016\/j.neuro.2007.12.006 (2008).","journal-title":"Neurotoxicology"},{"key":"31283_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13041-020-00654-w","volume":"13","author":"JY Koh","year":"2020","unstructured":"Koh, J. Y. & Lee, S. J. Metallothionein-3 as a multifunctional player in the control of cellular processes and diseases. Mol. Brain. 13, 116. https:\/\/doi.org\/10.1186\/s13041-020-00654-w (2020).","journal-title":"Mol. Brain"},{"key":"31283_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","volume":"11","author":"M Si","year":"2018","unstructured":"Si, M. & Lang, J. The roles of Metallothioneins in carcinogenesis. J. Hematol. Oncol. 11, 107. https:\/\/doi.org\/10.1186\/s13045-018-0645-x (2018).","journal-title":"J. Hematol. Oncol."},{"key":"31283_CR20","doi-asserted-by":"publisher","first-page":"114326","DOI":"10.1016\/j.ab.2021.114326","volume":"630","author":"AP Gunn","year":"2021","unstructured":"Gunn, A. P., McLean, C. A., Crouch, P. J. & Roberts, B. R. Quantification of metallothionein-III in brain tissues using liquid chromatography tandem mass spectrometry. Anal. Biochem. 630, 114326. https:\/\/doi.org\/10.1016\/j.ab.2021.114326 (2021).","journal-title":"Anal. Biochem."},{"key":"31283_CR21","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1039\/c4cs00138a","volume":"43","author":"KJ Barnham","year":"2014","unstructured":"Barnham, K. J. & Bush, A. I. Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chem. Soc. Rev. 43, 6727\u20136749. https:\/\/doi.org\/10.1039\/c4cs00138a (2014).","journal-title":"Chem. Soc. Rev."},{"key":"31283_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","volume":"74","author":"L Mezzaroba","year":"2019","unstructured":"Mezzaroba, L., Alfieri, D. F., Simao, C., Vissoci Reiche, E. M. & A. N. & The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology 74, 230\u2013241. https:\/\/doi.org\/10.1016\/j.neuro.2019.07.007 (2019).","journal-title":"Neurotoxicology"},{"key":"31283_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/17482960801934312","volume":"9","author":"I Hozumi","year":"2008","unstructured":"Hozumi, I. et al. The expression of Metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph. Lateral Scler. 9, 294\u2013298. https:\/\/doi.org\/10.1080\/17482960801934312 (2008).","journal-title":"Amyotroph. Lateral Scler."},{"key":"31283_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0014-5793(02)03546-9","volume":"531","author":"S Ishigaki","year":"2002","unstructured":"Ishigaki, S. et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords\u2013screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 531, 354\u2013358. https:\/\/doi.org\/10.1016\/s0014-5793(02)03546-9 (2002).","journal-title":"FEBS Lett."},{"key":"31283_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968. https:\/\/doi.org\/10.1093\/bioinformatics\/btq054 (2010).","journal-title":"Bioinformatics"},{"key":"31283_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-6918-0_7","volume":"124","author":"AP Gunn","year":"2017","unstructured":"Gunn, A. P. & Roberts, B. R. Analysis of trace elements and metalloproteins in fractionated human brain samples using size exclusion inductively coupled mass spectrometry. Neuromethods 124, 119\u2013125. https:\/\/doi.org\/10.1007\/978-1-4939-6918-0_7 (2017).","journal-title":"Neuromethods"},{"key":"31283_CR27","doi-asserted-by":"publisher","first-page":"35391","DOI":"10.1038\/srep35391","volume":"6","author":"T Jayasena","year":"2016","unstructured":"Jayasena, T. et al. Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci. Rep. 6, 35391. https:\/\/doi.org\/10.1038\/srep35391 (2016).","journal-title":"Sci. Rep."},{"key":"31283_CR28","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.msard.2020.102426","volume":"45","author":"M Sarmadi","year":"2020","unstructured":"Sarmadi, M. et al. Copper concentration in multiple sclerosis: a systematic review and meta-analysis. Mult Scler. Relat. Disord. 45, 102426. https:\/\/doi.org\/10.1016\/j.msard.2020.102426 (2020).","journal-title":"Mult Scler. Relat. Disord"},{"key":"31283_CR29","doi-asserted-by":"publisher","first-page":"127165","DOI":"10.1016\/j.jtemb.2023.127165","volume":"78","author":"A Kamalian","year":"2023","unstructured":"Kamalian, A. et al. Metal concentrations in cerebrospinal fluid, blood, serum, plasma, hair, and nails in amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Trace Elem. Med. Biol. 78, 127165. https:\/\/doi.org\/10.1016\/j.jtemb.2023.127165 (2023).","journal-title":"J. Trace Elem. Med. Biol."},{"key":"31283_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00216-018-1362-6","volume":"411","author":"K Kysenius","year":"2019","unstructured":"Kysenius, K. et al. A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samples. Anal. Bioanal Chem. 411, 603\u2013616. https:\/\/doi.org\/10.1007\/s00216-018-1362-6 (2019).","journal-title":"Anal. Bioanal Chem."},{"key":"31283_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41598-022-27169-9","volume":"13","author":"R Pamphlett","year":"2023","unstructured":"Pamphlett, R., Buckland, M. E. & Bishop, D. P. Potentially toxic elements in the brains of people with multiple sclerosis. Sci. Rep. 13, 655. https:\/\/doi.org\/10.1038\/s41598-022-27169-9 (2023).","journal-title":"Sci. Rep."},{"key":"31283_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s13311-018-0656-x","volume":"15","author":"AA Belaidi","year":"2018","unstructured":"Belaidi, A. A. et al. Marked Age-Related changes in brain iron homeostasis in amyloid protein precursor knockout mice. Neurotherapeutics 15, 1055\u20131062. https:\/\/doi.org\/10.1007\/s13311-018-0656-x (2018).","journal-title":"Neurotherapeutics"},{"key":"31283_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1039\/c8mt00223a","volume":"11","author":"A Lothian","year":"2019","unstructured":"Lothian, A. et al. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or Recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn. Metallomics 11, 128\u2013140. https:\/\/doi.org\/10.1039\/c8mt00223a (2019).","journal-title":"Metallomics"},{"key":"31283_CR34","doi-asserted-by":"publisher","unstructured":"Hancock, S. M. et al. Zinc Transporter-3 knockout mice demonstrate Age-Dependent alterations in the metalloproteome. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21030839 (2020).","DOI":"10.3390\/ijms21030839"},{"key":"31283_CR35","doi-asserted-by":"publisher","first-page":"22809","DOI":"10.1074\/jbc.M113.482091","volume":"288","author":"B Bjorkblom","year":"2013","unstructured":"Bjorkblom, B. et al. Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J. Biol. Chem. 288, 22809\u201322820. https:\/\/doi.org\/10.1074\/jbc.M113.482091 (2013).","journal-title":"J. Biol. Chem."},{"key":"31283_CR36","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1074\/jbc.M113.535112","volume":"289","author":"S Girotto","year":"2014","unstructured":"Girotto, S. et al. DJ-1 is a copper chaperone acting on SOD1 activation. J. Biol. Chem. 289, 10887\u201310899. https:\/\/doi.org\/10.1074\/jbc.M113.535112 (2014).","journal-title":"J. Biol. Chem."},{"key":"31283_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00216-001-1187-5","volume":"372","author":"AN Richarz","year":"2002","unstructured":"Richarz, A. N. & Bratter, P. Speciation analysis of trace elements in the brains of individuals with alzheimer\u2019s disease with special emphasis on Metallothioneins. Anal. Bioanal Chem. 372, 412\u2013417. https:\/\/doi.org\/10.1007\/s00216-001-1187-5 (2002).","journal-title":"Anal. Bioanal Chem."},{"key":"31283_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/abio.1994.1408","volume":"221","author":"CW Levenson","year":"1994","unstructured":"Levenson, C. W. & Janghorbani, M. Long-term measurement of organ copper turnover in rats by continuous feeding of a stable isotope. Anal. Biochem. 221, 243\u2013249. https:\/\/doi.org\/10.1006\/abio.1994.1408 (1994).","journal-title":"Anal. Biochem."},{"key":"31283_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska, A. et al. Wilson disease. Nat. Rev. Dis. Primers. 4, 21. https:\/\/doi.org\/10.1038\/s41572-018-0018-3 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"31283_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm1539","volume":"13","author":"PA Lang","year":"2007","unstructured":"Lang, P. A. et al. Liver cell death and anemia in Wilson disease involve acid Sphingomyelinase and ceramide. Nat. Med. 13, 164\u2013170. https:\/\/doi.org\/10.1038\/nm1539 (2007).","journal-title":"Nat. Med."},{"key":"31283_CR41","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529 (2022).","journal-title":"Science"},{"key":"31283_CR42","doi-asserted-by":"publisher","unstructured":"Patel, R. & Aschner, M. Commonalities between Copper Neurotoxicity and Alzheimer\u2019s Disease. Toxics 9, https:\/\/doi.org\/10.3390\/toxics9010004 (2021).","DOI":"10.3390\/toxics9010004"},{"key":"31283_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0022-510x(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, W. R. Copper, iron and zinc in alzheimer\u2019s disease senile plaques. J. Neurol. Sci. 158, 47\u201352. https:\/\/doi.org\/10.1016\/s0022-510x(98)00092-6 (1998).","journal-title":"J. Neurol. Sci."},{"key":"31283_CR44","doi-asserted-by":"publisher","unstructured":"Rembach, A. et al. Decreased copper in Alzheimer\u2019s disease brain is predominantly in the soluble extractable fraction. Int J Alzheimers Dis 623241 (2013). (2013). https:\/\/doi.org\/10.1155\/2013\/623241","DOI":"10.1155\/2013\/623241"},{"key":"31283_CR45","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1039\/c7mt00074j","volume":"9","author":"J Xu","year":"2017","unstructured":"Xu, J. et al. Evidence for widespread, severe brain copper deficiency in alzheimer\u2019s dementia. Metallomics 9, 1106\u20131119. https:\/\/doi.org\/10.1039\/c7mt00074j (2017).","journal-title":"Metallomics"},{"key":"31283_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1073\/pnas.0809057106","volume":"106","author":"PJ Crouch","year":"2009","unstructured":"Crouch, P. J. et al. Increasing Cu bioavailability inhibits Abeta oligomers and Tau phosphorylation. Proc. Natl. Acad. Sci. U S A. 106, 381\u2013386. https:\/\/doi.org\/10.1073\/pnas.0809057106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"31283_CR47","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/ar300074t","volume":"45","author":"PJ Crouch","year":"2012","unstructured":"Crouch, P. J. & Barnham, K. J. Therapeutic redistribution of metal ions to treat alzheimer\u2019s disease. Acc. Chem. Res. 45, 1604\u20131611. https:\/\/doi.org\/10.1021\/ar300074t (2012).","journal-title":"Acc. Chem. Res."},{"key":"31283_CR48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ejhg.2009.187","volume":"18","author":"Z Tumer","year":"2010","unstructured":"Tumer, Z. & Moller, L. B. Menkes disease. Eur. J. Hum. Genet. 18, 511\u2013518. https:\/\/doi.org\/10.1038\/ejhg.2009.187 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"31283_CR49","doi-asserted-by":"publisher","unstructured":"Horn, N. & Wittung-Stafshede, P. ATP7A-Regulated enzyme metalation and trafficking in the Menkes disease puzzle. Biomedicines 9 https:\/\/doi.org\/10.3390\/biomedicines9040391 (2021).","DOI":"10.3390\/biomedicines9040391"},{"key":"31283_CR50","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter, D. T. et al. Increased nigral iron content and alterations in other metal ions occurring in brain in parkinson\u2019s disease. J. Neurochem. 52, 1830\u20131836. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb07264.x (1989).","journal-title":"J. Neurochem"},{"key":"31283_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0006-8993(96)00782-2","volume":"738","author":"DA Loeffler","year":"1996","unstructured":"Loeffler, D. A. et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 738, 265\u2013274. https:\/\/doi.org\/10.1016\/s0006-8993(96)00782-2 (1996).","journal-title":"Brain Res."},{"key":"31283_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton, S. et al. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann. Neurol. 73, 554\u2013559. https:\/\/doi.org\/10.1002\/ana.23817 (2013).","journal-title":"Ann. Neurol."},{"key":"31283_CR53","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neurobiolaging.2013.09.034","volume":"35","author":"KM Davies","year":"2014","unstructured":"Davies, K. M. et al. Copper pathology in vulnerable brain regions in parkinson\u2019s disease. Neurobiol. Aging. 35, 858\u2013866. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.034 (2014).","journal-title":"Neurobiol. Aging"},{"key":"31283_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00401-017-1726-6","volume":"134","author":"BG Trist","year":"2017","unstructured":"Trist, B. G. et al. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in parkinson\u2019s disease brain. Acta Neuropathol. 134, 113\u2013127. https:\/\/doi.org\/10.1007\/s00401-017-1726-6 (2017).","journal-title":"Acta Neuropathol."},{"key":"31283_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/01.wnl.0000073542.02761.5f","volume":"61","author":"N Kumar","year":"2003","unstructured":"Kumar, N., Gross, J. B. Jr. & Ahlskog, J. E. Myelopathy due to copper deficiency. Neurology 61, 273\u2013274. https:\/\/doi.org\/10.1212\/01.wnl.0000073542.02761.5f (2003).","journal-title":"Neurology"},{"key":"31283_CR56","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4065\/81.10.1371","volume":"81","author":"N Kumar","year":"2006","unstructured":"Kumar, N. Copper deficiency myelopathy (human swayback). Mayo Clin. Proc. 81, 1371\u20131384. https:\/\/doi.org\/10.4065\/81.10.1371 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"31283_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00415-010-5511-x","volume":"257","author":"SR Jaiser","year":"2010","unstructured":"Jaiser, S. R. & Winston, G. P. Copper deficiency myelopathy. J. Neurol. 257, 869\u2013881. https:\/\/doi.org\/10.1007\/s00415-010-5511-x (2010).","journal-title":"J. Neurol."},{"key":"31283_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with Familial amyotrophic lateral sclerosis. Nature 362, 59\u201362. https:\/\/doi.org\/10.1038\/362059a0 (1993).","journal-title":"Nature"},{"key":"31283_CR59","doi-asserted-by":"publisher","first-page":"15923","DOI":"10.1074\/jbc.M112087200","volume":"277","author":"LJ Hayward","year":"2002","unstructured":"Hayward, L. J. et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with Familial amyotrophic lateral sclerosis. J. Biol. Chem. 277, 15923\u201315931. https:\/\/doi.org\/10.1074\/jbc.M112087200 (2002).","journal-title":"J. Biol. Chem."},{"key":"31283_CR60","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1002\/anie.202000451","volume":"60","author":"BG Trist","year":"2021","unstructured":"Trist, B. G., Hilton, J. B., Hare, D. J., Crouch, P. J. & Double, K. L. Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic. Angew Chem. Int. Ed. Engl. 60, 9215\u20139246. https:\/\/doi.org\/10.1002\/anie.202000451 (2021).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"31283_CR61","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jmb.2011.04.027","volume":"409","author":"P Ip","year":"2011","unstructured":"Ip, P., Mulligan, V. K. & Chakrabartty, A. ALS-causing SOD1 mutations promote production of copper-deficient misfolded species. J. Mol. Biol. 409, 839\u2013852. https:\/\/doi.org\/10.1016\/j.jmb.2011.04.027 (2011).","journal-title":"J. Mol. Biol."},{"key":"31283_CR62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnagi.2014.00110","volume":"6","author":"MW Bourassa","year":"2014","unstructured":"Bourassa, M. W., Brown, H. H., Borchelt, D. R., Vogt, S. & Miller, L. M. Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS. Front. Aging Neurosci. 6, 110. https:\/\/doi.org\/10.3389\/fnagi.2014.00110 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"31283_CR63","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","volume":"34","author":"BR Roberts","year":"2014","unstructured":"Roberts, B. R. et al. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a Transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 34, 8021\u20138031. https:\/\/doi.org\/10.1523\/JNEUROSCI.4196-13.2014 (2014).","journal-title":"J. Neurosci."},{"key":"31283_CR64","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1039\/c6mt00099a","volume":"8","author":"JB Hilton","year":"2016","unstructured":"Hilton, J. B., White, A. R. & Crouch, P. J. Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS. Metallomics 8, 1002\u20131011. https:\/\/doi.org\/10.1039\/c6mt00099a (2016).","journal-title":"Metallomics"},{"key":"31283_CR65","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.bbadis.2018.03.015","volume":"1864","author":"E Tokuda","year":"2018","unstructured":"Tokuda, E. et al. A copper-deficient form of mutant Cu\/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2119\u20132130. https:\/\/doi.org\/10.1016\/j.bbadis.2018.03.015 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"31283_CR66","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1038\/s41467-024-50514-7","volume":"15","author":"OJ Hale","year":"2024","unstructured":"Hale, O. J., Wells, T. R., Mead, R. J. & Cooper, H. J. Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A Transgenic mice implicates demetalation with pathology. Nat. Commun. 15, 6518. https:\/\/doi.org\/10.1038\/s41467-024-50514-7 (2024).","journal-title":"Nat. Commun."},{"key":"31283_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1471-4159.2009.06310.x","volume":"111","author":"E Tokuda","year":"2009","unstructured":"Tokuda, E., Okawa, E. & Ono, S. Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper\/zinc superoxide dismutase-linked Familial amyotrophic lateral sclerosis. J. Neurochem. 111, 181\u2013191. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06310.x (2009).","journal-title":"J. Neurochem"},{"key":"31283_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.nbd.2013.01.001","volume":"54","author":"E Tokuda","year":"2013","unstructured":"Tokuda, E., Okawa, E., Watanabe, S., Ono, S. & Marklund, S. L. Dysregulation of intracellular copper homeostasis is common to Transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol. Dis. 54, 308\u2013319. https:\/\/doi.org\/10.1016\/j.nbd.2013.01.001 (2013).","journal-title":"Neurobiol. Dis."},{"key":"31283_CR69","doi-asserted-by":"publisher","unstructured":"Liddell, J. R. et al. Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper. Metallomics 16 https:\/\/doi.org\/10.1093\/mtomcs\/mfae036 (2024).","DOI":"10.1093\/mtomcs\/mfae036"},{"key":"31283_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.expneurol.2018.06.006","volume":"307","author":"JB Hilton","year":"2018","unstructured":"Hilton, J. B., Kysenius, K., White, A. R. & Crouch, P. J. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1(G37R) mouse model of ALS and can be restored by overexpressing the human copper transporter hCTR1. Exp. Neurol. 307, 118\u2013128. https:\/\/doi.org\/10.1016\/j.expneurol.2018.06.006 (2018).","journal-title":"Exp. Neurol."},{"key":"31283_CR71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","volume":"188","author":"O 71 Torkildsen","year":"2008","unstructured":"71 Torkildsen, O., Brunborg, L. A., Myhr, K. M. & Bo, L. The Cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 188, 72\u201376. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01036.x (2008).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"31283_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","volume":"17","author":"M Zirngibl","year":"2022","unstructured":"Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V. & Plemel, J. R. Oligodendrocyte death and Myelin loss in the Cuprizone model: an updated overview of the intrinsic and extrinsic causes of Cuprizone demyelination. Mol. Neurodegener. 17, 34. https:\/\/doi.org\/10.1186\/s13024-022-00538-8 (2022).","journal-title":"Mol. Neurodegener"},{"key":"31283_CR73","doi-asserted-by":"publisher","first-page":"175909142211263","DOI":"10.1177\/17590914221126367","volume":"14","author":"ML Morgan","year":"2022","unstructured":"Morgan, M. L. et al. Cuprizone-induced demyelination in mouse brain is not due to depletion of copper. ASN Neuro. 14, 17590914221126367. https:\/\/doi.org\/10.1177\/17590914221126367 (2022).","journal-title":"ASN Neuro"},{"key":"31283_CR74","doi-asserted-by":"publisher","unstructured":"Hilton, J. B. W. et al. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice. Metallomics 16, https:\/\/doi.org\/10.1093\/mtomcs\/mfad072 (2024).","DOI":"10.1093\/mtomcs\/mfad072"},{"key":"31283_CR75","doi-asserted-by":"publisher","unstructured":"Colombo, E. et al. Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes. Proc. Natl. Acad. Sci. U S A 118, https:\/\/doi.org\/10.1073\/pnas.2025804118 (2021).","DOI":"10.1073\/pnas.2025804118"},{"key":"31283_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/exnr.2000.7323","volume":"162","author":"YH Gong","year":"2000","unstructured":"Gong, Y. H. & Elliott, J. L. Metallothionein expression is altered in a Transgenic murine model of Familial amyotrophic lateral sclerosis. Exp. Neurol. 162, 27\u201336. https:\/\/doi.org\/10.1006\/exnr.2000.7323 (2000).","journal-title":"Exp. Neurol."},{"key":"31283_CR77","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ana.1252","volume":"50","author":"MK Olsen","year":"2001","unstructured":"Olsen, M. K. et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A Transgenic mouse spinal cord. Ann. Neurol. 50, 730\u2013740. https:\/\/doi.org\/10.1002\/ana.1252 (2001).","journal-title":"Ann. Neurol."},{"key":"31283_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tox.2006.09.011","volume":"229","author":"E Tokuda","year":"2007","unstructured":"Tokuda, E. et al. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicology 229, 33\u201341. https:\/\/doi.org\/10.1016\/j.tox.2006.09.011 (2007).","journal-title":"Toxicology"},{"key":"31283_CR79","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1523\/JNEUROSCI.22-20-08790.2002","volume":"22","author":"K 79 Puttaparthi","year":"2002","unstructured":"79 Puttaparthi, K. et al. Disease progression in a Transgenic model of Familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J. Neurosci. 22, 8790\u20138796. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-20-08790.2002 (2002).","journal-title":"J. Neurosci."},{"key":"31283_CR80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2011.05.034","volume":"189","author":"K Hashimoto","year":"2011","unstructured":"Hashimoto, K., Hayashi, Y., Watabe, K., Inuzuka, T. & Hozumi, I. Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice. Neuroscience 189, 293\u2013298. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.05.034 (2011).","journal-title":"Neuroscience"},{"key":"31283_CR81","doi-asserted-by":"publisher","DOI":"10.3791\/53737","author":"A Lothian","year":"2016","unstructured":"Lothian, A. & Roberts, B. R. Standards for quantitative metalloproteomic analysis using size exclusion ICP-MS. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53737 (2016).","journal-title":"J. Vis. Exp."},{"key":"31283_CR82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1039\/c4mt00258j","volume":"7","author":"BR Roberts","year":"2015","unstructured":"Roberts, B. R. et al. Traumatic brain injury induces elevation of Co in the human brain. Metallomics 7, 66\u201370. https:\/\/doi.org\/10.1039\/c4mt00258j (2015).","journal-title":"Metallomics"},{"key":"31283_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1385\/bter:113:1:93","volume":"113","author":"S Ono","year":"2006","unstructured":"Ono, S. et al. Upregulation of metallothionein-I mRNA expression in a rodent model for amyotrophic lateral sclerosis. Biol. Trace Elem. Res. 113, 93\u2013104. https:\/\/doi.org\/10.1385\/bter:113:1:93 (2006).","journal-title":"Biol. Trace Elem. Res."},{"key":"31283_CR84","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1046\/j.0953-816x.2001.01512.x","volume":"13","author":"S Nagano","year":"2001","unstructured":"Nagano, S. et al. Reduction of Metallothioneins promotes the disease expression of Familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci. 13, 1363\u20131370. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01512.x (2001).","journal-title":"Eur. J. Neurosci."},{"key":"31283_CR85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13311-015-0346-x","volume":"12","author":"E Tokuda","year":"2015","unstructured":"Tokuda, E., Watanabe, S., Okawa, E. & Ono, S. Regulation of intracellular copper by induction of endogenous Metallothioneins improves the disease course in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 12, 461\u2013476. https:\/\/doi.org\/10.1007\/s13311-015-0346-x (2015).","journal-title":"Neurotherapeutics"},{"key":"31283_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3940(92)90727-o","volume":"144","author":"PA Sillevis Smitt","year":"1992","unstructured":"Sillevis Smitt, P. A., Blaauwgeers, H. G., Troost, D. & de Jong, J. M. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 144, 107\u2013110. https:\/\/doi.org\/10.1016\/0304-3940(92)90727-o (1992).","journal-title":"Neurosci. Lett."},{"key":"31283_CR87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuroscience.2018.07.009","volume":"388","author":"H Jakovac","year":"2018","unstructured":"Jakovac, H., Grubic Kezele, T. & Radosevic-Stasic, B. Expression profiles of Metallothionein I\/II and Megalin in Cuprizone model of De- and remyelination. Neuroscience 388, 69\u201386. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.07.009 (2018).","journal-title":"Neuroscience"},{"key":"31283_CR88","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1039\/c8mt00285a","volume":"11","author":"G Comes","year":"2019","unstructured":"Comes, G. et al. Mouse metallothionein-1 and metallothionein-2 are not biologically interchangeable in an animal model of multiple sclerosis, EAE. Metallomics 11, 327\u2013337. https:\/\/doi.org\/10.1039\/c8mt00285a (2019).","journal-title":"Metallomics"},{"key":"31283_CR89","doi-asserted-by":"publisher","unstructured":"Bousleiman, J. et al. Function of metallothionein-3 in neuronal cells: do metal ions alter expression levels of MT3? Int. J. Mol. Sci. 18 https:\/\/doi.org\/10.3390\/ijms18061133 (2017).","DOI":"10.3390\/ijms18061133"},{"key":"31283_CR90","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1111\/j.1742-4658.2010.07717.x","volume":"277","author":"P Faller","year":"2010","unstructured":"Faller, P. Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters. FEBS J. 277, 2921\u20132930. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07717.x (2010).","journal-title":"FEBS J."},{"key":"31283_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0361-9230(01)00452-x","volume":"55","author":"J Hidalgo","year":"2001","unstructured":"Hidalgo, J., Aschner, M., Zatta, P. & Vasak, M. Roles of the Metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55, 133\u2013145. https:\/\/doi.org\/10.1016\/s0361-9230(01)00452-x (2001).","journal-title":"Brain Res. Bull."},{"key":"31283_CR92","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1128\/MCB.23.23.8471-8485.2003","volume":"23","author":"B Zhang","year":"2003","unstructured":"Zhang, B. et al. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by Metallothionein. Mol. Cell. Biol. 23, 8471\u20138485. https:\/\/doi.org\/10.1128\/MCB.23.23.8471-8485.2003 (2003).","journal-title":"Mol. Cell. Biol."},{"issue":"Pt 3","key":"31283_CR93","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1042\/bj2920673","volume":"292","author":"AM Ferreira","year":"1993","unstructured":"Ferreira, A. M., Ciriolo, M. R., Marcocci, L. & Rotilio, G. Copper(I) transfer into Metallothionein mediated by glutathione. Biochem. J. 292 (Pt 3), 673\u2013676. https:\/\/doi.org\/10.1042\/bj2920673 (1993).","journal-title":"Biochem. J."},{"key":"31283_CR94","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1002\/anie.201916316","volume":"59","author":"A Santoro","year":"2020","unstructured":"Santoro, A. et al. The Glutathione\/Metallothionein system challenges the design of efficient O(2) -Activating copper complexes. Angew Chem. Int. Ed. Engl. 59, 7830\u20137835. https:\/\/doi.org\/10.1002\/anie.201916316 (2020).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"31283_CR95","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1093\/brain\/awac165","volume":"145","author":"BG Trist","year":"2022","unstructured":"Trist, B. G. et al. Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. Brain 145, 3108\u20133130. https:\/\/doi.org\/10.1093\/brain\/awac165 (2022).","journal-title":"Brain"},{"key":"31283_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","volume":"19","author":"JR Liddell","year":"2024","unstructured":"Liddell, J. R. et al. Microglial ferroptotic stress causes non-cell autonomous neuronal death. Mol. Neurodegener. 19, 14. https:\/\/doi.org\/10.1186\/s13024-023-00691-8 (2024).","journal-title":"Mol. Neurodegener"},{"key":"31283_CR97","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1352458510384010","volume":"17","author":"IY Choi","year":"2011","unstructured":"Choi, I. Y., Lee, S. P., Denney, D. R. & Lynch, S. G. Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler. 17, 289\u2013296. https:\/\/doi.org\/10.1177\/1352458510384010 (2011).","journal-title":"Mult Scler."},{"key":"31283_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2008.05.011","volume":"213","author":"E Tokuda","year":"2008","unstructured":"Tokuda, E. et al. Ammonium Tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exp. Neurol. 213, 122\u2013128. https:\/\/doi.org\/10.1016\/j.expneurol.2008.05.011 (2008).","journal-title":"Exp. Neurol."},{"key":"31283_CR99","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1126\/science.286.5449.2498","volume":"286","author":"AG Estevez","year":"1999","unstructured":"Estevez, A. G. et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498\u20132500. https:\/\/doi.org\/10.1126\/science.286.5449.2498 (1999).","journal-title":"Science"},{"key":"31283_CR100","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1046\/j.1471-4159.1997.69051936.x","volume":"69","author":"JP Crow","year":"1997","unstructured":"Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A. & Beckman, J. S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69, 1936\u20131944. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69051936.x (1997).","journal-title":"J. Neurochem"},{"key":"31283_CR101","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/21678421.2013.824000","volume":"14","author":"EJ McAllum","year":"2013","unstructured":"McAllum, E. J. et al. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 586\u2013590. https:\/\/doi.org\/10.3109\/21678421.2013.824000 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"31283_CR102","doi-asserted-by":"publisher","first-page":"42292","DOI":"10.1038\/srep42292","volume":"7","author":"JB Hilton","year":"2017","unstructured":"Hilton, J. B. et al. Cu(II)(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord. Sci. Rep. 7, 42292. https:\/\/doi.org\/10.1038\/srep42292 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31283-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:20:16Z","timestamp":1781637616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31283-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31283"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31283-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9598"}}